Dutch Startup CryoCloud Lands €2M to Automate Cryo-EM for Drug Discovery
Dutch startup CryoCloud, a provider of cloud-native tools for cryo-electron microscopy (cryo-EM) data analysis, has raised €2M in seed funding to further develop its automation-first SaaS platform. The round was led by Nina Capital and joined by Value Creation Capital, ROM Utrecht, and Utrecht Health Seed Fund, bringing total funding to €2.8M following a €500K pre-seed round in 2023.
CryoCloud’s platform supports high-throughput structural biology workflows, enabling users across 25+ countries (also researchers in academia, biotech, and pharma) to process large cryo-EM datasets with access to petabyte-scale storage and dozens of GPUs via a private or hybrid cloud setup. Recent developments include:
- Cryo-ET workflow
- Advanced data visualisation tools
- Proprietary algorithms
- ISO27001 certification
CEO Robert Englmeier, PhD, described the platform as the first turnkey cloud system for cryo-EM, claiming productivity gains and easier scaling of cryo-EM projects. CryoCloud leverages proprietary machine learning algorithms to analyze structural data at atomic resolution, aiming to reduce the cost, time, and hardware barriers that have historically limited adoption of cryo-EM outside of elite facilities.
Topic: Biotech Ventures
